Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CFO Sells 7,324 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CFO Alexis Desieno sold 7,324 shares of the company's stock in a transaction dated Wednesday, July 2nd. The shares were sold at an average price of $1.78, for a total transaction of $13,036.72. Following the sale, the chief financial officer directly owned 171,858 shares in the company, valued at approximately $305,907.24. This trade represents a 4.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Cardlytics Price Performance

CDLX stock traded up $0.07 during mid-day trading on Friday, reaching $1.87. 720,336 shares of the company traded hands, compared to its average volume of 999,467. Cardlytics, Inc. has a 52-week low of $1.22 and a 52-week high of $9.48. The company has a market capitalization of $97.91 million, a P/E ratio of -0.52 and a beta of 1.21. The company has a debt-to-equity ratio of 2.62, a current ratio of 1.19 and a quick ratio of 1.19. The company has a fifty day moving average price of $1.81 and a 200-day moving average price of $2.38.

Hedge Funds Weigh In On Cardlytics

Several hedge funds have recently bought and sold shares of the company. Charles Schwab Investment Management Inc. lifted its stake in Cardlytics by 3.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 402,552 shares of the company's stock worth $1,493,000 after purchasing an additional 12,209 shares in the last quarter. Brooktree Capital Management raised its position in shares of Cardlytics by 4.5% in the fourth quarter. Brooktree Capital Management now owns 175,210 shares of the company's stock worth $650,000 after buying an additional 7,568 shares in the last quarter. Intech Investment Management LLC raised its position in shares of Cardlytics by 31.3% in the fourth quarter. Intech Investment Management LLC now owns 19,310 shares of the company's stock worth $72,000 after buying an additional 4,607 shares in the last quarter. Virtu Financial LLC bought a new stake in Cardlytics during the fourth quarter valued at $62,000. Finally, Geode Capital Management LLC grew its position in Cardlytics by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 1,060,739 shares of the company's stock worth $3,936,000 after buying an additional 7,561 shares in the last quarter. Hedge funds and other institutional investors own 68.10% of the company's stock.

Wall Street Analyst Weigh In

CDLX has been the topic of several research reports. Evercore ISI lowered their price target on shares of Cardlytics from $4.00 to $3.00 and set an "in-line" rating on the stock in a research report on Thursday, March 13th. Lake Street Capital cut their price objective on shares of Cardlytics from $3.00 to $2.50 and set a "hold" rating for the company in a report on Thursday, May 8th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Cardlytics in a research note on Thursday, March 13th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $3.50.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.